Makoto Hamasaki

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto et al. · Lung Cancer · 2016 · 176 citations

Medicine, Oncology, Pathology +15

Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis

Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki et al. · Blood · 2005 · 169 citations · Full text

Medicine, Oncology, Pharmacology +16

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers

Shingo Nakahata, Tomonaga Ichikawa, Phudit Maneesaay et al. · Nature Communications · 2014 · 162 citations · Full text

Medicine, Molecular Biology, Oncology +16

p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells

Teru Hideshima, Klaus Podar, Dharminder Chauhan et al. · Oncogene · 2004 · 132 citations

Medicine, Oncology, Pharmacology +14

RETRACTED: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications

Yu‐Tzu Tai, Laurence Catley, Constantine S. Mitsiades et al. · Cancer Research · 2004 · 131 citations · Full text

Medicine, Cell Biology, Oncology +14